Author

D. Fernandois

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Research Focus:spatial domain detection· 1

Frequent Co-Authors

B. Klonjkowski· 1 shared C. Bedart· 1 shared C. F. F. Coelho· 1 shared C. Izabelle· 1 shared E. Cecon· 1 shared J. Dam· 1 shared J. Wenzel· 1 shared M. Schwaninger· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

B. Klonjkowski

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels

E. Cecon, D. Fernandois, N. Renault, C. F. F. Coelho, J. Wenzel, C. Bedart, C. Izabelle, S. Gallet, S. Le Poder, B. Klonjkowski, M. Schwaninger, V. PREVOT, J. Dam, R. Jockers

This study shows melatonin and its derivatives prevent SARS-CoV-2 brain entry and reduce cerebral damage in a mouse model.

bioRxiv · Dec 30, 2021Pharmacology & Toxicology

D. Fernandois · henhao